134 related articles for article (PubMed ID: 15227730)
21. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
23. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Rinne A; Weber E; Kosma VM
J Clin Pathol; 2007 May; 60(5):515-9. PubMed ID: 16790691
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
25. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells.
Geisen C; Denk C; Gremm B; Baust C; Karger A; Bollag W; Schwarz E
Cancer Res; 1997 Apr; 57(8):1460-7. PubMed ID: 9108446
[TBL] [Abstract][Full Text] [Related]
26. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
28. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
[TBL] [Abstract][Full Text] [Related]
29. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
Arrieta O; González-De la Rosa CH; Aréchaga-Ocampo E; Villanueva-Rodríguez G; Cerón-Lizárraga TL; Martínez-Barrera L; Vázquez-Manríquez ME; Ríos-Trejo MA; Alvarez-Avitia MA; Hernández-Pedro N; Rojas-Marín C; De la Garza J
J Clin Oncol; 2010 Jul; 28(21):3463-71. PubMed ID: 20547984
[TBL] [Abstract][Full Text] [Related]
31. Beta-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor beta expression.
Lian F; Hu KQ; Russell RM; Wang XD
Int J Cancer; 2006 Nov; 119(9):2084-9. PubMed ID: 16841329
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Lu C; Soria JC; Tang X; Xu XC; Wang L; Mao L; Lotan R; Kemp B; Bekele BN; Feng L; Hong WK; Khuri FR
J Clin Oncol; 2004 Nov; 22(22):4575-83. PubMed ID: 15542809
[TBL] [Abstract][Full Text] [Related]
34. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
35. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
36. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.
Hilbe W; Auberger J; Dirnhofer S; Schmid T; Erdel M; Duba HC
Oncol Rep; 2006 May; 15(5):1233-40. PubMed ID: 16596192
[TBL] [Abstract][Full Text] [Related]
37. A specific defect in the retinoic acid response associated with human lung cancer cell lines.
Zhang XK; Liu Y; Lee MO; Pfahl M
Cancer Res; 1994 Nov; 54(21):5663-9. PubMed ID: 7923214
[TBL] [Abstract][Full Text] [Related]
38. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
39. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
Jiang F; Caraway NP; Nebiyou Bekele B; Zhang HZ; Khanna A; Wang H; Li R; Fernandez RL; Zaidi TM; Johnston DA; Katz RL
Clin Cancer Res; 2005 Aug; 11(15):5417-24. PubMed ID: 16061856
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
